Julia Garza
Family Medicine · Saint Louis, MONPI 1235796616
Payments from drug & device makers
Across 232 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$996
- Gilead$708
- Lilly USA, LLC$307
- Novo Nordisk$265
- AbbVie$244
- Pfizer$209
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 56 | $996 |
| Gilead | 13 | $708 |
| Lilly USA, LLC | 18 | $307 |
| Novo Nordisk | 15 | $265 |
| AbbVie | 12 | $244 |
| Pfizer | 18 | $209 |
| Napo Pharmaceuticals Inc | 10 | $197 |
| Theratechnologies Inc. | 7 | $160 |
| Antares Pharma, Inc. | 8 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $124 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| Merck | 3 | $82 |
| Johnson & Johnson | 4 | $78 |
| EMD Serono, Inc. | 3 | $70 |
| Exact Sciences | 3 | $70 |
| Almatica Pharma LLC | 4 | $69 |
| AstraZeneca | 4 | $68 |
| Sanofi-aventis U.S. LLC | 2 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Boehringer Ingelheim | 3 | $53 |
| Amgen | 3 | $49 |
| Abbott | 2 | $47 |
| Lundbeck LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Electromed, Inc. | 5 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Novartis | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,611 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,497 |
| OzempicSemaglutide | 11 | $10,478 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,822 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $764 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $644 |
| Gabapentin | 25 | $559 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 11 | $551 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $512 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $420 |
| Pantoprazole Sodium | 26 | $264 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $240 |
| Atorvastatin Calcium | 23 | $239 |
| Mupirocin | 29 | $239 |
| Hydroxyzine Hcl | 12 | $234 |
| Alprazolam | 37 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $265 | $10,47811 claims |
| AstraZenecaSymbicort | $68 | $2,82212 claims |
| Almatica Pharma LLCSertraline Hcl | $69 | $4217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Rupal TrivediSaint Louis$10.6M
- Emily DoucetteSaint Louis$155K
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- Amanda BooneSaint Louis$17K
- David GlickSaint Louis$17K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.